CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $517.05 ($4,291,512)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $518.74 ($4,927,985)
- 144 Insider Sale of Securities
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $517.09 ($4,912,310)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $516.06 ($4,902,569)
- 144 Insider Sale of Securities
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $518.96 ($4,930,098)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $524.90 ($4,986,594)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $522.37 ($4,962,488)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $526.73 ($5,003,976)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.42 ($5,038,971)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $531.74 ($5,051,519)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $528.58 ($5,021,520)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 222 · 4,428 filings